Research Article
COL3A1 and Its Related Molecules as Potential Biomarkers in the Development of Human Ewing’s Sarcoma
Table 1
Relationship between the expression level of TGFB1 and clinical characteristics in ES.
| Characteristic | Low expression of TGFBI | High expression of TGFBI | |
| | 50 | 51 | | Metastasis, (%) | | | 0.686 | No | 39 (38.6%) | 37 (36.6%) | | Yes | 11 (10.9%) | 14 (13.9%) | | Tumor region, (%) | | | 1.000 | Distal | 18 (28.1%) | 18 (28.1%) | | Other | 2 (3.1%) | 1 (1.6%) | | Proximal | 12 (18.8%) | 13 (20.3%) | | Proximal and distal | 0 (0%) | 0 (0%) | | Age, (%) | | | 1.000 | <18 | 39 (38.6%) | 39 (38.6%) | | ≥18 | 11 (10.9%) | 12 (11.9%) | | Gender, (%) | | | 0.372 | Female | 23 (22.8%) | 18 (17.8%) | | Male | 27 (26.7%) | 33 (32.7%) | | Race, (%) | | | | American Indian or Alaska Native | 0 (0%) | 1 (1.3%) | | Asian | 3 (3.9%) | 4 (5.3%) | | Black or African American | 5 (6.6%) | 5 (6.6%) | | Native Hawaiian or other Pacific Islander | 0 (0%) | 0 (0%) | | White | 28 (36.8%) | 30 (39.5%) | | Age, median (IQR) | 15.27 (12.35, 17.69) | 15.06 (12.63, 17.77) | 0.989 |
|
|